You are here

Tcelna

On the ropes, Opexa shares blasted by PhIIb multiple sclerosis trial flop

Endpoints

Fri, 10/28/16 - 10:08 am

multiple sclerosis

clinical trials

Opexa Therapeutics provides update on Phase IIb trial

Yahoo/Fly on the Wall

Mon, 12/16/13 - 08:21 am

multiple sclerosis

Merck KGaA signs $225 million personalized MS drug deal

Pharma Times, UK

Wed, 02/6/13 - 11:11 am

multiple sclerosis